Inflammatory Bowel Disease Center at NYU Langone Health, 305 East 33rd Street, Lower Level, New York, NY 10016, USA.
Inflammatory Bowel Disease Center at NYU Langone Health, 305 East 33rd Street, Lower Level, New York, NY 10016, USA.
Gastroenterol Clin North Am. 2022 Sep;51(3):649-666. doi: 10.1016/j.gtc.2022.05.003. Epub 2022 Aug 30.
Inflammatory bowel diseases (IBD), including Crohn disease and ulcerative colitis, are chronic inflammatory conditions of the gastrointestinal tract. Individuals with IBD are at increased risk for several malignancies originating in the intestine, such as colorectal cancer, small bowel adenocarcinoma, intestinal lymphoma, and anal cancer. There are also several extraintestinal malignancies associated with IBD and IBD therapies, including cholangiocarcinoma, skin cancer, hematologic malignancies, genitourinary cancer, cervical cancer, and prostate cancer. The authors summarize the risk of cancer in patients with IBD, diagnosis and management of colorectal neoplasia in IBD, and management of patients with IBD and active or recent cancer.
炎症性肠病(IBD),包括克罗恩病和溃疡性结肠炎,是胃肠道的慢性炎症性疾病。IBD 患者发生起源于肠道的几种恶性肿瘤的风险增加,例如结直肠癌、小肠腺癌、肠淋巴瘤和肛门癌。IBD 及其治疗还与几种肠外恶性肿瘤相关,包括胆管癌、皮肤癌、血液系统恶性肿瘤、泌尿生殖系统癌症、宫颈癌和前列腺癌。作者总结了 IBD 患者的癌症风险、IBD 中结直肠肿瘤的诊断和管理,以及 IBD 合并活动期或近期癌症患者的管理。